Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan-Mar;45(1):113-115.
doi: 10.1016/j.htct.2021.08.011. Epub 2021 Nov 30.

Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia

Thamiris Silva Soares  1 , João Sávio Silva Soares  2 , Gabriela Lemes David  3
Affiliations
Case Reports

Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia

Thamiris Silva Soares et al. Hematol Transfus Cell Ther. 2023 Jan-Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors declare no conflicts of interest.

References

    1. Brabrand M, Frederiksen H. Risks of solid and lymphoid malignancies in patients with myeloproliferative neoplasms: clinical implications. Cancers (Basel) 2020 Oct;12(10):3061. - PMC - PubMed
    1. Rumi E, Passamonti F, Elena C, Pietra D, Arcaini L, Astori C, et al. Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. Haematologica. 2011;96(3):454–458. - PMC - PubMed
    1. Vannucchi AM, Masala G, Antonioli E, Susini MC, Guglielmelli P, Pieri L, et al. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2068–2073. - PubMed
    1. Masarova L, Newberry KJ, Pierce SA, Estrov Z, Cortes JE, Kantarjian HM, et al. Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: clinical characteristics, therapy and outcome. Leuk Res. 2015;39(8):822–827. - PMC - PubMed
    1. Khanal N, Giri S, Upadhyay S, Shostrom VK, Pathak R, Bhatt VR. Risk of second primary malignancies and survival of adult patients with polycythemia vera: a United States population-based retrospective study. Leuk Lymphoma. 2016;57(1):129–133. - PubMed

Publication types